İnsan çevirisi örneklerinden çeviri yapmayı öğrenmeye çalışıyor.
Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
palifermiinia verrattiin lumelääkkeeseen.
palifermin was compared with placebo (a dummy treatment).
Son Güncelleme: 2012-04-10
Kullanım Sıklığı: 3
Kalite:
yksi injektiopullo sisältää 6,25 mg palifermiinia.
each vial contains 6.25 mg of palifermin
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 6
Kalite:
käyttövalmiiksi saatettu kepivance sisältää 5 mg/ml palifermiinia
reconstituted kepivance contains 5 mg/ml of palifermin
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
jokainen injektiopullo sisältää 6, 25 mg vaikuttavaa ainetta palifermiinia.
each vial contains 6.25 mg of the active substance palifermin.
Son Güncelleme: 2012-04-10
Kullanım Sıklığı: 3
Kalite:
tässä tutkimuksessa 212 potilasta sai satunnaistetusti joko palifermiinia tai lumevalmistetta.
in this study, 212 patients were randomised and received either palifermin or placebo.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 4
Kalite:
vaikuttava aine on palifermiini.yksi injektiopullo sisältää 6, 25 mg palifermiinia.
what kepivance containsthe active substance is palifermin.each vial contains 6.25 mg of palifermin.
Son Güncelleme: 2008-03-04
Kullanım Sıklığı: 1
Kalite:
Uyarı: Bu hizalama yanlış olabilir..
Böyle düşünüyorsanız lütfen silin.
palifermiinia saaneilla potilailla ei havaittu viitteitä hematopoieesin hitaammasta elpymisestä lumevalmistetta saaneisiin potilaisiin verrattuna.
there was no evidence of a delay in time to haematopoietic recovery in patients who received palifermin as compared to patients who received placebo.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
palifermiinia ei siis tule antaa potilaille, joilla on diagnosoitu muu kuin pahanlaatuinen verisairaus tai joilla epäillään sellaista.
palifermin should therefore not be given to patients with known or suspected non-haematological malignancies.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
kepivance sisältää vaikuttavana aineena palifermiinia, joka on biotekniikan menetelmillä escherichia coli -bakteereissa tuotettu valkuaisaine.
kepivance contains the active substance palifermin which is a protein produced by biotechnology in a bacteria called escherichia coli.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 4
Kalite:
koska potilaista on tietoja niukasti, hepariineja on käytettävä varoen potilaille, jotka saavat palifermiinia, ja asianmukaisia verenhyytymistestejä on suoritettava hoidon seuraamiseksi.
due to limited data in patients, heparins should be used with care in patients receiving palifermin and appropriate blood coagulation tests should be carried out to monitor their treatment.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
palifermiinia annettiin päivittäin 60 mikrogrammaa/ kg injektiona laskimoon kolmena peräkkäisenä päivänä ennen sytotoksisen hoidon aloittamista ja kolmena peräkkäisenä päivänä perifeerisen veren kantasoluinfuusion jälkeen.
palifermin was administered as a daily intravenous injection of 60 micrograms/ kg for 3 consecutive days prior to initiation of cytotoxic therapy and for 3 consecutive days following infusion of peripheral blood progenitor cells.
Son Güncelleme: 2012-04-10
Kullanım Sıklığı: 3
Kalite:
palifermiinin farmakokinetiikassa ei havaittu eroja sukupuolten välillä.
no gender-related differences were observed in the pharmacokinetics of palifermin.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 4
Kalite: